M&A Deal Summary |
|
---|---|
Date | 2014-04-17 |
Target | Michael Foods, Inc. |
Sector | Food |
Buyer(s) | Post Holdings, Inc. |
Sellers(s) | Goldman Sachs Merchant Banking |
Deal Type | Add-on Acquisition |
Deal Value | 2.5B USD |
Advisor(s) | Barclays Investment Bank Bank of America Merrill Lynch (BofA Securities) Goldman Sachs Investment Banking Division (Financial) Fried Frank Harris Shriver & Jacobson LLP (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1895 |
Sector | Food |
Employees | 10,735 |
Revenue | 6.2B USD (2021) |
Post Holdings is a consumer packaged goods holding company, operating in the center-of-the-store, foodservice, ingredient, refrigerated, active nutrition and private label food categories. Post Holdings was founded in 1895 and is based in St. Louis, Missouri.
DEAL STATS | # |
---|---|
Overall | 5 of 15 |
Sector (Food) | 3 of 11 |
Type (Add-on Acquisition) | 4 of 10 |
State (Minnesota) | 1 of 2 |
Country (United States) | 4 of 12 |
Year (2014) | 4 of 7 |
Size (of disclosed) | 1 of 10 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-02-03 |
Dymatize Enterprises LLC
Farmers Branch, Texas, United States Dymatize Enterprises is a manufacturer and marketer of branded and private label nutritional and sports supplements. Dymatize offers more than 250 branded and private label products in numerous categories. |
Buy | $380M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-10-01 |
PowerBar, Inc.
Glendale, California, United States PowerBar was created by athletes, for athletes. Company started PowerBar to help athletes reach their goals by providing nutrition tools for optimum athletic performance. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1986 |
PE ASSETS | 155.0B USD |
Size | Mega |
Type | Sector Agnostic |
Goldman Sachs Merchant Banking Division is the investment arm of Goldman Sachs. The primary corporate investment group within the Merchant Banking Division is Goldman Sachs' direct investment arm. GS's direct investment arm consists of GS Capital Partners, GS Mezzanine Partners, and GS Growth Partners. GS Capital Partners is the direct corporate equity investment group which seeks LBO, recapitalization, and growth investments to help fund acquisitions, expansions, recapitalizations, restructurings, buyouts, and take privates. GS Capital Partners looks to invest between $50 and $800 million in opportunities in North/South America, Europe, Asia. GS Mezzanine Partners is the junior capital arm of Goldman Sachs. GS Mezzanine looks to invest between $200 million and and $800 million in transactions valued up to $10 billion. Investment proceeds are used to fund leveraged buyouts, expansion financings, recapitalizations, acquisitions, and restructurings. GS Growth looks to invest in growth equity transactions. The unit seeks to commit $20 to $200 million per investment. Other units within GS's merchant banking division include Real Estate, Infrastructure, and Urban Investments. Goldman Sachs Merchant Banking Division is based in New York City.
DEAL STATS | # |
---|---|
Overall | 47 of 104 |
Sector (Food) | 1 of 3 |
Type (Add-on Acquisition) | 10 of 33 |
State (Minnesota) | 1 of 2 |
Country (United States) | 34 of 73 |
Year (2014) | 3 of 10 |
Size (of disclosed) | 7 of 29 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-04-11 |
Flint Group Germany GmbH
Ahaus-Ottenstein, Germany Flint Group is a leading supplier of diversified consumable graphic arts products to the global printing, converting, and colorants industry. Inks include packaging inks, heatset inks (used primarily for printing glossy magazines), coldset inks (both colour and black newspaper ink), sheet-fed inks (short-run commercial applications) and publication gravure inks (high-run printed media). |
Buy | €2.2B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-04-24 |
Biomet, Inc.
Warsaw, Indiana, United States Biomet, Inc. is a designs and manufactures orthopedic medical devices and other products used primarily by surgeons and medical specialists, with distribution in over 70 countries and a product portfolio that encompasses orthopedic joint replacement products, dental reconstructive implants, fixation devices, spinal products and other applications. |
Sell | $13.4B |